TNF-MM11B-100μg / 询价
TNF-MM11B-500μg / 询价
TNF-MM11B-500μgx2 / 询价
- 客服电话
- 技术支持
Mouse TNFRSF11B Protein
Recombinant Mouse TNFRSF11B Protein is expressed from HEK293 with His tag at the C-Terminus. It contains Glu22-Leu401.[Accession | O08712]
The protein has a predicted MW of 44.53 kDa. Due to glycosylation, the protein migrates to 55-65 kDa based on Tris-Bis PAGE result.
Less than 1EU per μg by the LAL method.
> 95% as determined by Tris-Bis PAGE
Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
-20 to -80°C for 12 months as supplied from date of receipt.
-80°C for 3-6 months after reconstitution.
2-8°C for 2-7 days after reconstitution.
Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Mouse TNFRSF11B on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Osteoprotegerin (OPG) is a key regulator in bone metabolism, that also has effect in vascular system. Studies suggest that osteoprotegerin is a critical arterial calcification inhibitor, and is released by endothelial cells as a protective mechanism for their survival in certain pathological conditions, such as diabetes mellitus, chronic kidney disease, and other metabolic disorders.
Osteoprotegerin; Ocif; Opg; PDB5; TR1;
Makarović S, Makarović Z, Steiner R, Mihaljević I, Milas-Ahić J. Osteoprotegerin and Vascular Calcification: Clinical and Prognostic Relevance. Coll Antropol. 2015 Jun;39(2):461-8. PMID: 26753467.
